FUrTIHF: French urinary tract infections in healthcare facilities - five-year historic cohort (2014-2018).


Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 26 01 2021
revised: 19 04 2021
accepted: 19 04 2021
pubmed: 25 6 2021
medline: 6 10 2021
entrez: 24 6 2021
Statut: ppublish

Résumé

Urinary tract infections (UTIs) are common and diverse. Even when not severe, UTIs regularly lead to hospitalization, but their hospital burden remains unknown. This study aimed to estimate the national incidence of hospitalized UTIs in France. A historic five-year cohort of adult patients hospitalized with UTIs in France was extracted from the medico-administrative databases using an ICD-10 code algorithm built by a multidisciplinary team. The performance parameters were estimated blindly, by reviewing 1122 cases, using medical reports as the gold standard, giving a global predictive positive value of 70.4% (95% confidence interval 66.6-74.1). The national incidence of UTIs was then estimated. A total of 2,083,973 patients with UTIs were hospitalized over the period, giving an adjusted incidence rate of ∼900 cases/100,000 inhabitants, stable over the period, higher in females and increasing with age; 1.2% were device-associated UTIs. Unspecific acute cystitis represented almost two-thirds of cases (63.5%); followed by pyelonephritis (23.6%) and prostatitis (12.4%). More than three-quarters of patients had at least one comorbid condition (76.8%). This national cohort study is the first to date to estimate the incidence of UTI-related hospitalizations in France. UTIs represent a substantial burden of care. Further analysis will provide data for more informed goal-of-care discussions targeting each type of UTI, their management and outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Urinary tract infections (UTIs) are common and diverse. Even when not severe, UTIs regularly lead to hospitalization, but their hospital burden remains unknown. This study aimed to estimate the national incidence of hospitalized UTIs in France.
METHODS METHODS
A historic five-year cohort of adult patients hospitalized with UTIs in France was extracted from the medico-administrative databases using an ICD-10 code algorithm built by a multidisciplinary team. The performance parameters were estimated blindly, by reviewing 1122 cases, using medical reports as the gold standard, giving a global predictive positive value of 70.4% (95% confidence interval 66.6-74.1). The national incidence of UTIs was then estimated.
RESULTS RESULTS
A total of 2,083,973 patients with UTIs were hospitalized over the period, giving an adjusted incidence rate of ∼900 cases/100,000 inhabitants, stable over the period, higher in females and increasing with age; 1.2% were device-associated UTIs. Unspecific acute cystitis represented almost two-thirds of cases (63.5%); followed by pyelonephritis (23.6%) and prostatitis (12.4%). More than three-quarters of patients had at least one comorbid condition (76.8%).
CONCLUSIONS CONCLUSIONS
This national cohort study is the first to date to estimate the incidence of UTI-related hospitalizations in France. UTIs represent a substantial burden of care. Further analysis will provide data for more informed goal-of-care discussions targeting each type of UTI, their management and outcomes.

Identifiants

pubmed: 34166732
pii: S0195-6701(21)00225-5
doi: 10.1016/j.jhin.2021.04.035
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-36

Informations de copyright

Copyright © 2021 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Auteurs

S de Lafforest (S)

EpiDcliC, unité de santé publique, SIMEES, CHRU de Tours, France; Faculté de médecine, Université de Tours, France; Equipe EA 7505 Education éthique santé, Université de Tours, France.

A Magnier (A)

CHU d'Angers, service d'urologie, Université Angers, France; Service d'urologie, CHRU de Tours, France.

M Vallée (M)

Department of Urology, Poitiers University Hospital, Université de Poitiers INSERM U1070, "Pharmacologie des Anti-Infectieux", Poitiers, France; CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France.

E Bey (E)

CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Urology and Andrology department, University Hospital of Nîmes, Nîmes, France.

C Le Goux (C)

CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Urologie Hôpital Privé Nord Parisien, Tassigy, Sarcelles, France.

F Saint (F)

CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Department of Urology and Transplantation, CHU Amiens-Picardie. EPROAD Laboratory EA 4669, Picardie Jules Verne University, France.

A Therby (A)

CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; CH Versailles, France.

J R Zahar (JR)

CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Infection Control Unit, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Bobigny, France; University Sorbonne Paris Nord, Bobigny, France.

A Sotto (A)

CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Service de maladies infectieuses et tropicales, CHU de Nimes, Université de Nimes, France.

F Bruyere (F)

Faculté de médecine, Université de Tours, France; Service d'urologie, CHRU de Tours, France; CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France.

L Grammatico-Guillon (L)

EpiDcliC, unité de santé publique, SIMEES, CHRU de Tours, France; Faculté de médecine, Université de Tours, France; CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France. Electronic address: leslie.guillon@univ-tours.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH